These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1666665)

  • 41. Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells.
    Feoktistov I; Murray JJ; Biaggioni I
    Mol Pharmacol; 1994 Jun; 45(6):1160-7. PubMed ID: 8022409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP.
    Iyú D; Glenn JR; White AE; Fox SC; Dovlatova N; Heptinstall S
    Platelets; 2011; 22(7):504-15. PubMed ID: 21591981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N-Ethylmaleimide induces disaggregation of platelets preaggregated by ADP and thrombin and decreases cytoplasmic calcium level.
    Samal AB; Loiko EN
    Biochemistry (Mosc); 2000 Feb; 65(2):230-6. PubMed ID: 10713553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of mercury in platelet aggregation--probable mechanism of action.
    Chaudhury S; Mukhopadhyay B; Bose S; Bhattacharya S
    Biomed Environ Sci; 1996 Mar; 9(1):26-36. PubMed ID: 8721624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conditions that lithium inhibits or potentiates vasopressin V1-receptor-mediated platelet aggregation and [Ca++]i mobilization.
    Dehpour AR; Kiani K; Ghafourifar P; Mousavizadeh K
    Gen Pharmacol; 1995 Dec; 26(8):1659-67. PubMed ID: 8745153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Physiological implications of adenosine receptor-mediated platelet aggregation.
    Johnston-Cox HA; Yang D; Ravid K
    J Cell Physiol; 2011 Jan; 226(1):46-51. PubMed ID: 20717958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiplatelet activity of tetramethylpyrazine.
    Liu SY; Sylvester DM
    Thromb Res; 1994 Jul; 75(1):51-62. PubMed ID: 8073408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of non-steroid anti-inflammatory drugs, dibutyryl cyclic 3',5'-adenosine monophosphate and phosphodiesterase inhibitors on platelet aggregation and the platelet release reaction in normal and essential fatty acid deficient rats.
    Vincent JE; Zijlstra FJ; Bonta IL
    Prostaglandins; 1975 Nov; 10(5):899-911. PubMed ID: 175400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Identification and determination of platelet aggregation inhibitor from safflower (Carthamus tinctorius Linné)].
    Kutsuna H; Fujii S; Kitamura K; Komatsu K; Nakano M
    Yakugaku Zasshi; 1988 Nov; 108(11):1101-3. PubMed ID: 3251021
    [No Abstract]   [Full Text] [Related]  

  • 50. Platelet aggregation inhibitors. X. S-Substituted 2-thioadenosines and their derivatives.
    Kikugawa K; Suehiro H; Aoki A
    Chem Pharm Bull (Tokyo); 1977 Oct; 25(10):2624-7. PubMed ID: 589709
    [No Abstract]   [Full Text] [Related]  

  • 51. Postprandial hyperlipemia does not inhibit platelet aggregation.
    Bisovsky S; Richter H; Fitscha P; O'Grady J; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 1992 Dec; 47(4):331-2. PubMed ID: 1302485
    [No Abstract]   [Full Text] [Related]  

  • 52. BM-1, a platelet aggregation inhibitor from mackerel.
    Honda J; Iwamoto M; Schichijo S; Oizumi K; Yokoyama M
    Lancet; 1991 Sep; 338(8770):817. PubMed ID: 1681179
    [No Abstract]   [Full Text] [Related]  

  • 53. Platelet aggregation inhibitors. IX. Chemical transformation of adenosine into 2-thioadenosine derivatives.
    Kikugawa K; Suehiro H; Yanase R; Aoki A
    Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):1959-69. PubMed ID: 922979
    [No Abstract]   [Full Text] [Related]  

  • 54. Isolation of an inhibitor of platelet aggregation from a fungus, Ganoderma lucidum.
    Shimizu A; Yano T; Saito Y; Inada Y
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):3012-5. PubMed ID: 4085058
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of probenecid on platelet aggregation and cytotoxicity: drawbacks of the use of probenecid in monitoring intracellular calcium metabolism.
    Chung SH; Kim MJ; Lee JY; Chung JH
    Thromb Res; 1997 Feb; 85(4):345-50. PubMed ID: 9062958
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyclic guanidines. IX. Synthesis of 2-amino-3,4-dihydroquinazolines as blood platelet aggregation inhibitors.
    Ishikawa F; Watanabe Y; Saegusa J
    Chem Pharm Bull (Tokyo); 1980 May; 28(5):1357-64. PubMed ID: 7408040
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of flomoxef on human platelet aggregation.
    Cazzola M; Matera MG; Gusmitta A; Rossi F
    Eur J Clin Pharmacol; 1991; 41(5):503-4. PubMed ID: 1761085
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro effect of cimetidine on platelet aggregation.
    Mikhailidis DP; Barradas MA; Jeremy JY; Dandona P
    Thromb Res; 1985 May; 38(3):307-8. PubMed ID: 4024046
    [No Abstract]   [Full Text] [Related]  

  • 59. [Mechanism of action of adenosine on intracellular calcium and platelet aggregation].
    Feoktistov IA; Pol S; Khollister AS; Robertson D; Biadzhoni I
    Kardiologiia; 1991 Nov; 31(11):76-9. PubMed ID: 1666665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation.
    Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I
    Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.